Loading...
A review of the pharmacology and clinical efficacy of brivaracetam
Brivaracetam (BRV; Briviact) is a new antiepileptic drug (AED) approved for adjunctive treatment of focal (partial-onset) seizures in adults. BRV is a selective, high-affinity ligand for synaptic vesicle 2A (SV2A) with 15- to 30-fold higher affinity than levetiracetam, the first AED acting on SV2A....
Na minha lista:
| Udgivet i: | Clin Pharmacol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5783144/ https://ncbi.nlm.nih.gov/pubmed/29403319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S114072 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|